HOBA THERAPEUTICS
Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
HOBA THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Total Employee:
1+
Status:
Active
Total Funding:
2 M USD
Similar Organizations
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
Carrick Therapeutics
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
Funxional Therapeutics
Funxional Therapeutics develops pharmaceutical products focusing on the treatment of various diseases and disorders.
Inexia
Inexia aims to develop intranasally administered orexin positive modulators for the treatment of neurological diseases.
Orexia
Orexia aims to develop orally administered orexin positive modulators for the treatment of neurological diseases.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Employees Featured
Founder
Investors List
Novo Holdings
Novo Holdings investment in Seed Round - Hoba Therapeutics
Borean Innovation
Borean Innovation investment in Seed Round - Hoba Therapeutics
More informations about "Hoba Therapeutics"
About us - Hoba Therapeutics
Hoba Therapeutics Aps Ole Maaløesvej, 2200 Copenhagen, Denmark CVR: DK 38231170See details»
Hoba Therapeutics - Crunchbase Company Profile & Funding
Hoba Therapeutics may be growing as it has successfully raised €23 million in a Series A funding round, which is a significant financial milestone for the company. This capital injection will …See details»
Pipeline - Hoba Therapeutics
Hoba Therapeutics holds the rights to two novel biopharmaceutical drugs – HB-086 and HB-097, currently in development for the treatment of chronic pain disorders and hearing loss, respectively. HB-086 and HB-097 are therapeutic …See details»
Hoba Therapeutics - LinkedIn
Hoba Therapeutics is a Danish biotech developing restorative treatments for chronic pain disorders and hearing loss. Both indications have a clear unmet medical need for safe and …See details»
Hoba Therapeutics raises EUR 23 million in a Series A to advance …
Hoba Therapeutics, a Novo Holdings founded Danish biotech company dedicated to developing novel therapeutic proteins for patients living with chronic neuropathic pain and hearing loss, …See details»
Hoba Therapeutics - PitchBook
Hoba Therapeutics General Information Description. Developer of medical therapeutics designed to assist neuropathic pain and CNS disorders treatments. The company specializes in developing novel biopharmaceuticals for the …See details»
Hoba Therapeutics raises EUR 23 million in a Series A to advance …
Dec 11, 2023 Hoba Therapeutics, a Novo Holdings-founded Danish biotech company dedicated to developing novel therapeutic proteins for patients living with chronic neuropathic pain and …See details»
Hoba Therapeutics Company Profile - Office Locations ... - Craft
Hoba Therapeutics is a company developing biopharmaceuticals for the treatment of pain and CNS disorders. It offers HB-086, human recombinant meteorin for the use in neuropathy and …See details»
Diseases - Hoba Therapeutics
Hoba Therapeutics focuses on developing novel treatments for two large indications with clear unmet needs for novel, safe and efficacious medications. Neuropathic Pain. Chronic neuropathic pain is a significant global health …See details»
Hoba Therapeutics - DevelopmentAid
Oct 11, 2024 Hoba Therapeutics — Consulting Organization from Denmark, has experience with Horizon Europe (2021 - 2027), it`s involved in Health, Science & Innovation sectors. Our …See details»
Hoba Therapeutics - Crunchbase
Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.See details»
Hoba Therapeutics - Funding, Financials, Valuation & Investors
Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much …See details»
Hoba Therapeutics raises EUR 23 million in a Series A to advance …
COPENHAGEN, Denmark, Dec. 11, 2023 /PRNewswire/ -- Hoba Therapeutics, a Novo Holdings-founded Danish biotech company dedicated to developing novel therapeutic proteins for …See details»
Novo Holdings-founded Hoba Therapeutics raises EUR 23 million …
About Hoba Therapeutics Hoba Therapeutics is a Danish biotech developing restorative treatments for chronic pain disorders and hearing loss. Both indications have a clear unmet …See details»
Hoba Therapeutics raises EUR 23 million
Hoba Therapeutics, a Novo Holdings founded Danish biotech company dedicated to developing novel therapeutic proteins for patients living with chronic neuropathic pain and hearing loss, …See details»
Hoba Therapeutics - Contacts, Employees, Board Members
Organization. Hoba Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of …See details»
Recombinant human meteorin (Hoba Therapeutics) - Drug Targets …
About Hoba Therapeutics Hoba Therapeutics is a Danish biotech developing restorative treatments for chronic pain disorders and hearing loss. Both indications have a clear unmet …See details»
News - Hoba Therapeutics
Dec 11, 2023 Hoba Therapeutics raises EUR 23 million in a Series A to advance new drug candidate against chronic neuropathic pain Copenhagen, December 11, 2023 Hoba …See details»
Series A - Hoba Therapeutics - 2023-12-10 - Crunchbase
Dec 10, 2023 Hoba Therapeutics raised $24760070 on 2023-12-10 in Series A. Indaco Venture Partners Indaco Venture Partners is an asset management company that invests in the …See details»